Univest
Univest
  • Markets

IREDA Q2 Results 2026 Today: Should You Buy Ahead of Earnings?

  • October 19, 2026
  • Posted by: Kunal Singla
  • Category: News
No Comments
IREDA Q2 Results 2026 Today: Should You Buy Ahead of Earnings?

IREDA Q2 results are due on Monday 19 Oct 2026. The stock traded near Rs 109.79 at 9:33 AM IST, about 30% below its 52-week high of Rs 156.75 (my calculation). FY26 profit rose 10% to Rs 1,873 crore on a gross loan portfolio of Rs 93,069 crore, and the board declared fraud on Gensol Engineering at its AGM on 29 Sep. I did not find Q2 FY26 baseline figures or analyst estimates, so this is a checklist and not a preview with numbers.

Quick Answer

IREDA Q2 results for the September 2026 quarter are due on 19 October, and the stock was trading near Rs 109.79 in the morning, up about 0.9% from Rs 108.80. The numbers that decide the reaction are loan book growth, disbursements, net interest margin and asset quality, since FY26 closed with a gross loan portfolio of Rs 93,069 crore and record disbursements of Rs 34,946 crore. The Gensol Engineering fraud declaration at the 29 September AGM makes provisions and exposure the most closely watched line in the IREDA Q2 results. Buying before IREDA Q2 results is a bet on an unknown number, so the stock can gap either way and I did not find analyst estimates to measure a beat or miss.

IREDA is a government-owned lender that finances renewable energy projects. It closed its insider trading window from 1 October 2026 ahead of the results, which is standard before a board meeting on quarterly numbers.

This guide covers the share price setup, the FY26 base, what to check in the IREDA Q2 results, the Gensol issue, the risks of buying ahead of earnings and what to watch after the numbers. It is educational and not a recommendation to buy or sell IREDA.

Click Here – Get Free Investment Predictions

Table of Contents

Toggle
  • IREDA Share Price Setup Ahead of the Results
  • FY26 Base: What IREDA Q2 Results Will Be Compared With
  • What to Check in the IREDA Q2 Results
  • The Gensol Issue and Management News Before the IREDA Q2 Results
  • Should You Buy Ahead of IREDA Q2 Results?
  • What to Watch Next
  • Conclusion
  • Frequently Asked Questions
    • When are the IREDA Q2 results?
    • What was IREDA’s FY26 profit and loan book?
    • What is the IREDA share price today?
    • What is the Gensol issue for IREDA?
    • What should I check in the IREDA Q2 results?
    • Are there analyst estimates for IREDA Q2 results?
    • Is it safe to buy IREDA ahead of earnings?
    • Is this article investment advice?

IREDA Share Price Setup Ahead of the Results

Item Detail Source or basis
Price at 9:33 AM IST, 19 Oct Rs 109.79, up 0.91% from Rs 108.80 Live quote
Day range so far Rs 108.51 to Rs 109.99 Live quote
52-week high and low Rs 156.75 and Rs 103.41 Live quote
Below the 52-week high About 30% My calculation
Above the 52-week low About 6% My calculation
Price on 5 Oct About Rs 109.10, down 1.7% that day Report dated 5 Oct

The stock has traded in a narrow band near Rs 109 for two weeks, so the IREDA Q2 results can move it out of that range. A narrow range before earnings means the market is waiting, and the reaction is often larger than the daily average.

Screen PSU stocks on the Univest Screener

FY26 Base: What IREDA Q2 Results Will Be Compared With

Metric FY26 Note
Profit after tax Rs 1,873 crore Up 10%
Gross loan portfolio Rs 93,069 crore Year-end
Record disbursements Rs 34,946 crore Full year
Q2 FY26 profit and revenue (base for IREDA Q2 results) Not found in the sources I read Needed to judge YoY growth
IREDA Q2 results analyst estimates Not found No beat or miss can be confirmed

Without the Q2 FY26 base for the IREDA Q2 results, I cannot say what YoY growth the market expects. Check the company’s filing for the IREDA Q2 results for the comparison, and compare Q2 with Q1 FY27 for the sequential trend.

What to Check in the IREDA Q2 Results

Line item Why it matters Warning sign
Loan book growth and disbursements Shows demand for renewable project loans Disbursements falling against the FY26 pace
Net interest margin and spread IREDA earns the gap between lending and borrowing rates Margin shrinking as funding costs rise
Gross and net NPA Asset quality drives the valuation of a lender A rise from the Gensol exposure
Provisions Show how much stress is being recognised A sharp jump in provisioning
Sanctions and pipeline Indicate future disbursements Slower sanctions
Management commentary Guidance on growth and credit cost Vague or lowered targets

The IREDA Q2 results also matter for the renewable sector, since the loan book reflects how many solar, wind and hydro projects are being financed. Higher global yields and a weak rupee can raise costs for borrowers.

Download the Univest iOS App or Univest Android App to track IREDA and set price alerts.

The Gensol Issue and Management News Before the IREDA Q2 Results

At its 39th AGM on 29 September 2026, IREDA declared fraud against Gensol Engineering. A fraud classification usually leads to full provisioning, so the Q2 numbers or commentary may show how much IREDA has set aside. I did not find the amount of the exposure in the sources I read, so check the filing.

The Ministry of New and Renewable Energy also granted a three-month extension to CMD Dr. Bijay Kumar Mohanty. Leadership continuity is a mild positive, but it does not replace clarity on credit quality.

Risk: If the Gensol provisioning is larger than expected, profit can fall even if the loan book grows.

Should You Buy Ahead of IREDA Q2 Results?

Approach Upside Downside
Buy before the IREDA Q2 results Capture a rally if numbers beat Gap down if provisions or margin disappoint
Wait for the numbers and commentary Trade on facts, not guesses May miss the first move
Stay out Avoid event risk May miss a re-rating

None of these is a recommendation. The point is that earnings are an event risk, and a lender with a fraud exposure carries more of it. If you hold the stock, decide in advance how much loss you can accept on a gap down.

What to Watch Next

  1. The IREDA Q2 results filing: profit, net interest income, NPAs and provisions
  2. Management commentary on Gensol and credit cost
  3. Loan sanctions and disbursement guidance for the second half
  4. The stock’s reaction relative to its Rs 103.41 low and Rs 156.75 high
  5. Renewable sector policy and funding news from MNRE

Conclusion

The IREDA Q2 results come with an open question on asset quality after the Gensol fraud declaration, and no consensus numbers to measure against. Read the filing before acting, and treat any pre-result position as a risk you can afford.

Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).

Frequently Asked Questions

When are the IREDA Q2 results?

Ans. They are due on Monday 19 October 2026 for the September quarter. I could not confirm the announcement time.

What was IREDA’s FY26 profit and loan book?

Ans. Profit after tax rose 10% to Rs 1,873 crore, the gross loan portfolio was Rs 93,069 crore and record disbursements were Rs 34,946 crore.

What is the IREDA share price today?

Ans. It traded near Rs 109.79 at 9:33 AM IST on 19 October, up about 0.9%, with a 52-week range of Rs 103.41 to Rs 156.75.

What is the Gensol issue for IREDA?

Ans. IREDA declared fraud against Gensol Engineering at its AGM on 29 September 2026. The exposure amount was not in the sources I read.

What should I check in the IREDA Q2 results?

Ans. Loan book growth, disbursements, net interest margin, gross and net NPA, provisions, sanctions and management commentary.

Are there analyst estimates for IREDA Q2 results?

Ans. I did not find any in the sources I read, so a beat or a miss cannot be confirmed.

Is it safe to buy IREDA ahead of earnings?

Ans. No outcome is guaranteed. The stock can gap either way, and the Gensol exposure adds event risk.

Is this article investment advice?

Ans. No. It is educational and not a recommendation to buy or sell.



ireda gensol ireda q2 results IREDA Share Price PSU Stocks q2 results today renewable energy lender
Author: Kunal Singla
Kunal Singla is the Associate Director - Research at Univest, leading quantitative equity research, intraday trading setups, and derivatives strategy. With 4+ years of experience in Indian equity markets, he combines rigorous quantitative methods with classical technical analysis to build high-conviction research frameworks for retail and advisory clients. He holds an MSc from the Indian Institute of Technology (IIT) Delhi — one of India's most selective institutions — and has completed the Certificate in Quantitative Finance (CQF), a globally recognised programme covering derivatives pricing, risk modelling, machine learning for finance, and advanced portfolio theory. This combination places him in a small group of Indian analysts with both deep academic training in quantitative methods and SEBI-recognised research credentials. Kunal holds seven SEBI-recognised NISM certifications spanning research, derivatives, portfolio management, and securities operations: Series-XV (Research Analyst), Series-XXI-A (Portfolio Managers), Series-XVI (Commodity Derivatives), Series-VIII (Equity Derivatives), Series-VII (SORM), Series-V-A (Mutual Fund Distributors), and Series-I (Currency Derivatives). At Univest — India's SEBI-registered research and advisory platform — Kunal leads research inputs for Pro Lite, Pro Super, Pro Gold, and Pro Commodity advisory services, alongside publishing intraday stock picks on Univest Blogs.

Leave a Reply Cancel reply